Notice it also includes Baylor College of Medicine, who are not only licencing Gradalis IP, but also won an NIH grant last year for T Cell gene therapy using shRNA.
http://www.bcm.edu/news/item.cfm?newsID=6286
i didn't see a direct link between shRNA GT and the bluebird programme yet, but it's warm, very warm.
BLT Price at posting:
30.0¢ Sentiment: Buy Disclosure: Held